BIOMAP project aims to improve lives of people with atopic dermatitis & psoriasis
BIOMAP have released a short animation which aims to demonstrate BIOMAP’s project work to alleviate the burden and consequences of AD and psoriasis for people living with these diseases. BIOMAP – Biomarkers in Atopic Dermatitis and Psoriasis What is BIOMAP? BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) is a large European project which launched in […]
First-in-class eczema drug dupilumab now available in Ireland
Life-changing biologic treatment, dupilumab, is now available to people with moderate to severe eczema in Ireland. The HSE has advised that effective from 1st April 2021, reimbursement of dupilumab will be available under High Tech Arrangements for the treatment of moderate-to-severe refractory atopic dermatitis (AD) in adults and adolescents 12 years and older for whom […]
Seasonal UV Changes and Protecting Our Skin
Knowing a little bit about Earth’s relationship with the Sun allows us to understand how the intensity of the Sun’s rays can change during the year, and the importance of protecting our skin. What causes the change in seasons? Earth revolves around the Sun, taking a year to complete one orbit. But as it does […]
Study for people aged 18-65, living with psoriasis, eczema or ichthyosis vulgaris
Are you aged 18-65 and living with psoriasis, eczema or ichthyosis vulgaris? You may be eligible to participate in a study to investigate the role of neutrophil proteases as global regulators of IL-1 family cytokine activity in skin disorders. NEUTROPRO Study The NEUTROPRO study is a research study being carried out by Professor Irvine (Dermatology […]
Can a writing intervention help improve body image in adults with a skin condition?
Does your skin or hair condition affect how you feel about your body? If the answer is yes, you may be interested in helping psychologists at the University of Sheffield test whether a one-week online writing intervention could improve body image in individuals living with a dermatological condition. Who can take part? You are eligible […]
Survey exploring the wellbeing of young people during the COVID-19 outbreak
This study is now closed. The University College Dublin (UCD) School of Psychology, in collaboration with the Dún Laoghaire-Rathdown Children’s and Young Peoples’ Services Committee (CYPSC) and Healthy Ireland, are running an online anonymous survey examining how the COVID-19 pandemic may have impacted the mental health and wellbeing of young people aged 12-25 years. The […]
This Valentine’s Day, Love your Skin and Avoid an Eczema Flare
Our tips to avoid an eczema flare this Valentine’s Day! We know that some of you may be buying your loved one some special gifts or having a romantic date night in, so we’ve put together some tips to ensure an eczema flare doesn’t spoil your Valentine’s Day. Investing quality time If you plan on […]
Tips to Prepare for a Remote/Virtual Hospital Consultation
The ever-evolving COVID-19 situation has had an impact on society in many ways, which has meant that hospitals and dermatology departments have had to change the way they interact with their patients. In order to ensure ongoing treatment and continuity of care, patients may be offered a telephone or video call, instead of face-to-face appointments. […]
Survey: New Phase of First Patient-Led Impact Research Study in Dermatology
The GRIDD project is the first global patient-initiated and patient-led impact research study in dermatology. Global Research on the Impact of Dermatological Diseases (GRIDD) was launched in 2017 by the International Alliance of Dermatology Patient Organizations (GlobalSkin). The ISF, a proud member of GlobalSkin, are calling on any adult affected by a skin condition to […]
Update on Dupilumab: HSE Management Supports Reimbursement
Less than a month from the last major development, Dupilumab receives green light for funding In a statement to the ISF and healthcare professionals this afternoon, the HSE notified patients that the Executive Management Team has supported reimbursement of Dupilumab under High Tech (Drugs Scheme) Arrangements. Availability of the new ‘first-in-class’ treatment will be “subject to […]
